Relationship Between the Regulation of Caspase-8-Mediated Apoptosis and Radioresistance in Human THP-1-Derived Macrophages
Overview
Chemistry
Molecular Biology
Affiliations
Radiosensitivity varies depending on the cell type; highly differentiated cells typically exhibit greater radioresistance. We recently demonstrated that human macrophages derived from THP-1 monocytic cells, which lack , are highly resistant to radiation-induced apoptosis compared with undifferentiated THP-1 cells. However, the mechanisms by which THP-1 cells acquire radioresistance during differentiation remain unknown. Herein, we investigated the mechanisms by which THP-1-derived macrophages develop p53-independent radioresistance by analyzing DNA damage responses and apoptotic pathways. Analysis of γ-H2AX foci, which indicates the formation of DNA double-strand breaks (DSB), suggested that a capacity to repair DSB of macrophages is comparable to that of radiosensitive THP-1 cells. Furthermore, treatment with inhibitors against DSB repair-related proteins failed to enhance radiation-induced apoptosis in THP-1-derrived macrophages. Analysis of the apoptotic pathways showed that radiosensitive THP-1 cells undergo apoptosis through the caspase-8/caspase-3 cascade after irradiation, whereas this was not observed in the macrophages. Caspase-8 protein expression was lower in macrophages than in THP-1 cells, whereas mRNA expressions were comparable between both cell types. Co-treatment with a proteasome inhibitor and ionizing radiation effectively induced apoptosis in macrophages in a caspase-8-dependent manner. Results suggest that the regulation of caspase-8-mediated apoptosis during differentiation plays a role in the p53-independent radioresistance of THP-1-derived macrophages.
cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells.
Nyui T, Yoshino H, Nunota T, Sato Y, Tsuruga E Cells. 2022; 11(9).
PMID: 35563740 PMC: 9101626. DOI: 10.3390/cells11091434.
How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
Medvedeva G, Kuzmina D, Nuzhina J, Shtil A, Dukhinova M Int J Mol Sci. 2021; 22(5).
PMID: 33800829 PMC: 7961970. DOI: 10.3390/ijms22052662.
Sato Y, Yoshino H, Kashiwakura I, Tsuruga E Int J Mol Sci. 2021; 22(1).
PMID: 33401559 PMC: 7795940. DOI: 10.3390/ijms22010420.
Bai G, Matsuba T, Niki T, Hattori T Int J Mol Sci. 2020; 21(22).
PMID: 33187327 PMC: 7696453. DOI: 10.3390/ijms21228490.
Hazawa M, Yoshino H, Nakagawa Y, Shimizume R, Nitta K, Sato Y Cancers (Basel). 2020; 12(4).
PMID: 32276424 PMC: 7226044. DOI: 10.3390/cancers12040908.